Haploidentical Allogeneic Cell Transplantation in Relapsed/Refractory Multiple Myeloma
In this small, selected cohort, haploidentical allogeneic HCT with individualized pre-treatment and conditioning regimens was associated with disease control in heavily pretreated patients with r/r MM.
Authors
- Anke Morgner
- Claudia Brogsitter
- Friedrich Stölzel (ORCID: https://orcid.org/0000-0003-0653-5332)
- Desireé Kunadt (ORCID: https://orcid.org/0000-0001-8750-5308)
- Julia Frimmel
- Raphael Teipel (ORCID: https://orcid.org/0000-0002-9985-6583)
- Mathias Hänel
- Christoph Röllig
- Karolin Trautmann-Grill
- Martin Bornhäuser
- Johannes Schetelig
Institutions
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- National Center for Tumor Diseases (DE)
- University Hospital Schleswig-Holstein (DE)
- University Hospital Carl Gustav Carus (DE)
- Klinikum Chemnitz (DE)
- Deutsche Knochenmarkspenderdatei (DE)
- Hochschule für Technik und Wirtschaft Dresden – University of Applied Sciences (DE)
- Technische Universität Dresden (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- Cancer Management and Research
- Published
- 2026-02-01
- DOI
- https://doi.org/10.2147/cmar.s564588
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00